About
Cellular Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular TherapySouthwestern U.S.
Clinical Trials (41)
View allTotal Trials
41
As Lead Sponsor
37
As Collaborator
4
Total Enrollment
2,245
By Phase
PHASE1/PHASE2: 8PHASE2: 7PHASE1: 21PHASE3: 2
By Status
COMPLETED: 19UNKNOWN: 12TERMINATED: 6ACTIVE_NOT_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1SUSPENDED: 1
Clinical Trials Pipeline41 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05292859Lead Sponsor
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
N/ACompleted
7 participants
Started: Mar 1, 2023 · Completed: May 30, 2025
NCT05194735Lead Sponsor
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
180 participants
Started: Apr 4, 2022 · Completed: Nov 30, 2024
NCT05124743Lead Sponsor
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
N/ATerminated
19 participants
Started: Sep 24, 2021 · Completed: Aug 14, 2023
NCT04006119Lead Sponsor
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
PHASE2Terminated
40 participants
Started: Aug 1, 2019 · Completed: Aug 5, 2021
NCT03679754Lead Sponsor
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
PHASE1Completed
36 participants
Started: Sep 5, 2018 · Completed: Jan 19, 2021
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...